DE602005017626D1 - Antivirale verwendung von borinsäurekomplexen - Google Patents

Antivirale verwendung von borinsäurekomplexen

Info

Publication number
DE602005017626D1
DE602005017626D1 DE602005017626T DE602005017626T DE602005017626D1 DE 602005017626 D1 DE602005017626 D1 DE 602005017626D1 DE 602005017626 T DE602005017626 T DE 602005017626T DE 602005017626 T DE602005017626 T DE 602005017626T DE 602005017626 D1 DE602005017626 D1 DE 602005017626D1
Authority
DE
Germany
Prior art keywords
acid complexes
borinic acid
antiviral use
antiviral
borinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005017626T
Other languages
English (en)
Inventor
Carolyn Bellinger-Kawahara
Kirk R Maples
Jacob J Plattner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anacor Pharmaceuticals Inc
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of DE602005017626D1 publication Critical patent/DE602005017626D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005017626T 2004-06-14 2005-06-14 Antivirale verwendung von borinsäurekomplexen Active DE602005017626D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14
PCT/US2005/020978 WO2006085932A2 (en) 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes

Publications (1)

Publication Number Publication Date
DE602005017626D1 true DE602005017626D1 (de) 2009-12-24

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017626T Active DE602005017626D1 (de) 2004-06-14 2005-06-14 Antivirale verwendung von borinsäurekomplexen

Country Status (13)

Country Link
US (1) US7393856B2 (de)
EP (1) EP1765360B1 (de)
JP (1) JP2008502694A (de)
AT (1) ATE447960T1 (de)
BR (1) BRPI0512049A (de)
CA (1) CA2570577A1 (de)
DE (1) DE602005017626D1 (de)
ES (1) ES2333244T3 (de)
HK (1) HK1102702A1 (de)
MX (1) MXPA06014417A (de)
PT (1) PT1765360E (de)
TW (1) TW200612967A (de)
WO (1) WO2006085932A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009522274A (ja) * 2005-12-28 2009-06-11 アナコール ファーマシューティカルズ,インコーポレイテッド ピコリネートボリン酸エステル類の製造方法
RS54108B1 (en) 2006-02-16 2015-12-31 Anacor Pharmaceuticals Inc. SMALL MOLECULES CONTAINING BORON AS AGENTS FOR INFLAMMATION
WO2010018836A2 (ja) * 2008-08-11 2010-02-18 独立行政法人科学技術振興機構 ポリグルタミン凝集阻害剤
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
PT2950644T (pt) 2013-01-30 2017-08-16 Agrofresh Inc Utilização de benzoxaboróis como agentes antimicrobianos voláteis em carnes, plantas ou partes de planta
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
CA3015662A1 (en) 2016-03-07 2017-09-14 Agrofresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (de) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. Neuartige oxaborolanaloga und verwendungen davon
TWI794742B (zh) * 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
EP4204012A1 (de) 2020-08-31 2023-07-05 Pfizer Inc. Verfahren zum schutz von rna

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2376965A1 (en) * 1999-07-07 2001-01-11 Timothy Patrick Forsyth Peptide boronic acid inhibitors of hepatitis c virus protease
AU2003299821B2 (en) * 2002-12-18 2010-02-18 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Also Published As

Publication number Publication date
JP2008502694A (ja) 2008-01-31
BRPI0512049A (pt) 2008-02-06
CA2570577A1 (en) 2006-08-17
ATE447960T1 (de) 2009-11-15
WO2006085932A2 (en) 2006-08-17
HK1102702A1 (en) 2007-11-30
WO2006085932A3 (en) 2006-10-05
TW200612967A (en) 2006-05-01
EP1765360B1 (de) 2009-11-11
ES2333244T3 (es) 2010-02-18
PT1765360E (pt) 2009-12-24
US7393856B2 (en) 2008-07-01
EP1765360A2 (de) 2007-03-28
MXPA06014417A (es) 2007-03-08
US20060019927A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
DE602005017626D1 (de) Antivirale verwendung von borinsäurekomplexen
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
EA201100390A1 (ru) Соединения для лечения гепатита с
CY1110084T1 (el) Χρηση συμπυκνωμενων ετεροκυκλικων ενωσεων ως αναστολεις scce για την θεραπευτικη αγωγη δερματικων ασθενειων
NO20070782L (no) Tetrapeptidanaloger.
EA201170521A1 (ru) Новые соединения
DE50310516D1 (de) Fredericamycin-derivate
UA85559C2 (en) Aminobenzophenone compounds
NO20060664L (no) N-substituerte benzimidazolyl C-kit inhibitorer
DE502006002886D1 (de) Dipyridyl-dihydropyrazolone und ihre verwendung 4- (pyridin-3-yl) -2- (pyridin-2-yl) -1,2-dihydro-3h-pyrazol-3-on derivate als spezifische hemmstoffe der hif-prolyl-4-hydroxylasen zur behandlung kardiovaskulärer und hämatologischer erkrankungen
DE60319406D1 (de) Meso-substituierte porphyrine
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
ATE432260T1 (de) Pyridinderivate als pkc-theta-hemmer
ATE445406T1 (de) Verwendung von eisen(iii)-komplexverbindungen
BR0310055A (pt) Derivados de piridinacarboxamida pesticidas
DE502005002176D1 (de) Substituierte chinolone
ATE420099T1 (de) Medikament zur wachstumsinhibierung von tumoren
TW200610530A (en) Anti-parasitic uses of borinic acid complexes
DE60328603D1 (de) Prodrugs von imidazol-derivaten, zur verwendung als protonenpumpen-hemmer zur behandlung von z.b. peptischen magengeschwüren
WO2005080549A3 (de) Trioxacarcine und deren verwendung gegen infektionskrankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition